You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1131 Anti-CLEC2D-TLR9 agonist conjugate binds to and internalizes CLEC2D on myeloid cells, plasmacytoid DCs and B cells leading to robust TLR pathway activation and inflammatory cytokine production

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1131 Anti-CLEC2D-TLR9 agonist conjugate binds to and internalizes CLEC2D on myeloid cells, plasmacytoid DCs and B cells leading to robust TLR pathway activation and inflammatory cytokine production

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023190029
Dec 202359014
Jan 20245705
Feb 20242206
Mar 202464011
Apr 202438011
May 20243406
Jun 20245408
Jul 20245406
Aug 20241203
Sep 20243403
Oct 20241606
Nov 20241604
Dec 20241004
Jan 20252409
Feb 2025406
Mar 20250023
Apr 2025002
May 2025009
Jun 2025004
Total6880169